期刊文献+

白细胞介素-17在糖尿病大鼠肾脏表达及其与α-平滑肌肌动蛋白的关系 被引量:1

Association of interleukin-17 on the expression in the renal of rats with diabete and a smooth muscle actin
原文传递
导出
摘要 目的观察白细胞介素,17(IL-17)在糖尿病大鼠肾组织的表达,探讨其参与。肾小管-间质病变的机制。方法55只雄性sD大鼠,随机选择35只以50mg/kg链脲佐菌素(STZ)制备糖尿病大鼠模型,剩余20只为正常对照组。于2、4周末采用酶联免疫吸附试验(ELISA)方法检测血、尿中IL-17。4周末采用免疫组织化学染色及Westemblot检测。肾组织中IL-17、α-平滑肌肌动蛋白(仅.SMA)及核因子-κBp65(NF.KBp65)。结果糖尿病组大鼠2周末血、尿中IL-17水平分别为(11.51±5.62)、(79.21±14.53)ng/L,与对照组比较差异有统计学意义[(8.87±3.35)、(6.75±1.13)ng/L,P〈0.01],4周末升高更明显;IL-17在正常对照组肾组织无表达,仅在糖尿病大鼠肾小管和肾间质中高表达。糖尿病大鼠。肾组织中IL-17表达与尿中IL-17(r=0.715,P〈0.05)及肾组织中d.SMA(r=0.708,P〈0.05)、NF—KBp65(r=0.638,P〈0.01)表达均呈正相关。结论IL-17参与糖尿病肾病早期肾小管-间质病变的可能机制为促进仪-SMA表达增加。 Objective To investigate the association between the expression of interleukin-17 (IL-17) in renal tubuleinterstitium and diabetic nephropathy. Methods 55 rats were randomly divided in- to three groups: control group, diabetic rat group. Diabetic rat group was injected 50 mg/kg streptozoticin (STZ). In the 2th, 4th week, serum and urine IL-17 were measured with enzyme-linked immunosorbent as- say (ELISA). The expression of IL-17, α-smooth muscle actin (cL-SMA) and nuclear factor-KB p65 (NF-KB p65) in the kidney were assessed by immunohistochemisty staining and Western blotting. Results Serum and urine IL-17 in diabetic rats were [ ( 11.51 ±5.62), (79. 21 ± 14. 53) ng/L], which were sig- nificantly upreguated as compared with those in control group rats ( P 〈 0.01 ), which were [ ( 8. 87 ± 3.35), (6. 75 ± 1.13) ng/L]. The expression of IL-17 was only observed in renal tubuleinterstitium of diabetic rats, the expression of IL-17 in renal tubuleinterstitium of diabetic rats was positively correlated with urine IL-17 ( r = 0. 715, P 〈 0.05 ), and the expression of ct-SMA ( r = 0. 708, P 〈 0. 05 ), NF-KB p65 ( r = 0. 638, P 〈 0. 01 ) in renal. Conclusion The effect of IL-17 on pathogenesis and progression of diabetic nephropathy in diabetic rat might be up-regulating the expression of α-SMA.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2013年第4期772-774,F0003,共4页 Chinese Journal of Experimental Surgery
基金 湖北省自然科学基金资助项目(2012FFB04306)
关键词 白细胞介素一17 糖尿病 肾小管 间质 Α-平滑肌肌动蛋白 核因子-ΚB Interleukin-17 Diabetes, renal tubular-interstitial α-smooth muscle actin Nuclear factor-kappa B
  • 相关文献

参考文献8

  • 1Fornoni A, Ijaz A, Tejada T, et al. Role of inflammation in diabetic ne- phropathy. Curr Diabetes Rev ,2008,4 : 10-17.
  • 2王德亮,邢德国,王亮,吴建军,田克立,刘中浩,宫明智.胰岛素样生长因子-1基因转染骨髓间质干细胞移植对糖尿病大鼠骨折愈合的影响[J].中华实验外科杂志,2012,29(3):518-520. 被引量:6
  • 3Goldberg RB. Cytokine and cytokine-like inflammation markers, endo- thelial dysfunction, and imbalanced coagulation in development of dia- betes and its complications. J Clin Endocrinol Metab,2009,94:3171- 3182.
  • 4魏文,李娟娟,孙圣荣,王卫星.乳腺癌小鼠动物模型中白细胞介素-17的表达及其意义[J].中华实验外科杂志,2011,28(5):673-675. 被引量:11
  • 5Paust HJ, Turner JE, Steinmetz OM, et al. The IL-23/Th17 axis con- tributes to renal injury in experimental glomerulonephritis. J Am Soc Nephrol, 2009,20 : 969 -979.
  • 6Masszi A, Fan L, Rosivall L, et al, Integrity of cell-cell contacts is a critical regulator of TGF-beta 1 induced eoithelial-to-myofibroblast transition : role for beta-catenin. Am J Pathol,2004,165 : 1955.
  • 7Li L, Emmett N, Mann D, et al. Fenofibrate attenuates tubulointerstitial fibrosis and inflammation through suppression of nuclear factor-KB and transforming growth factor-131/Smad3 in diabetic nephropathy. Exp Bi- ol Med,2010,235:383-591.
  • 8Kuhad A, Chopra K. Attenuation of diabetic nephropathy by tocotrien- ol :involvement of NFkB signaling pathway. Life Sci, 2009,84 : 296- 301.

二级参考文献21

  • 1唐立群,宫明智,刘中浩,司海朋,邢德国,赵敬杰.糖尿病大鼠骨折愈合过程中骨钙素的变化[J].中华实验外科杂志,2006,23(4):617-618. 被引量:15
  • 2姚晓莉,童鹤翔,涂毅,姚峰,王卫星,孙圣荣.CCL5及其受体在乳腺癌组织中的表达及其意义[J].中华实验外科杂志,2007,24(5):590-592. 被引量:15
  • 3Afzali B,Lombardi G,Lechler HI,et al.The role of T helper 17 (Th 17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease.Clin Exp Immunol,2007,148:32-46.
  • 4Harrington LE,Hatton RD,Mangan PR,et al.Interleukin 17-producing CD4 + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.Nat Immunol,2005,6:1123-1132.
  • 5Fossiez F,Banchereau J,Murray R,et al.Interleukin-17.Int Rev Immunol,1998,16:541 -551.
  • 6Zhang B,Rong G,Wei H,et al.The prevalence of Thl7 cells in patients with gastric cancer.Biochem Biophys Res Commun,2008,374:533-537.
  • 7Le Gouvello S,Bastuji-Garin S,Aloulou N,et al.High prevalence of Foxp3 and IL-17 in MMR-proficient colorectal carcinomas.Gut,2008,57:772-779.
  • 8Numasaki M,Watanabe M,Suzuki T,et al.IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenes(i)s.J Immunol,2005,175:6177-6189.
  • 9Shime H.Yabu M.Akazawa T,et al.Tumor-secreted lactic acid promotes IL-23/IL-17 proinflammatory pathway.J Immunol,2008,180:7175-7183.
  • 10Kryczek I,Wei S,Zou L,et al.Cutting edge:Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment.Immunol,2007,178:6730-6733.

共引文献15

同被引文献6

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部